Ciclosporin A (CyA) was the cornerstone of rescue medical therapy for steroid-refractory acute severe colitis until the advent of anti-TNF agents. CyA is a competitive calcinuerin inhibitor with ...

The shoot was set up by the Business Disability Forum to create its Disability Smart Image Bank, which businesses and media ...

Learn about the new guidelines released by the AGA for pharmacological management of moderate-to-severe ulcerative colitis.

Dr. Raymond Cross of Mercy Medical Center joins Jennifer Franciotti for a conversation about ulcerative colitis - how it ...

The causes of ulcerative colitis aren't quite known, but women of child-bearing age should be especially vigilant for ...

However, approximately 15% of patients with ulcerative colitis will develop a severe exacerbation and require hospitalization. While many patients with acute severe ulcerative colitis will respond ...

very severe long term side effects. Most of the agents that we use for treating ulcerative colitis work both for induction of remission so getting the acute symptoms better but also for ...

Scientists have identified a gene that can help doctors predict which patients are likely to develop severe ulcerative ...

The American Gastroenterological Association (AGA) has released a new clinical guideline on the pharmacological management of moderate-to-severe ulcerative colitis, published in Gastroenterology.